Themis Medicare's Stock Reaches All-Time High, Outperforms Sector and Sensex

Themis Medicare, a smallcap pharmaceutical company, has been making headlines in the stock market as its share price reached an all-time high on November 18, 2024. The stock, which is currently trading at Rs 301.5, is just 0.93% away from its 52-week high of Rs 304.3.

According to MarketsMOJO, a leading stock market analysis platform, the stock has been given a 'Hold' rating. It has also outperformed the sector by 8.95% and has been on a consecutive gain for the last 2 days, with a 14.77% increase in returns during this period. The stock also opened with a gain of 8.84% today, indicating a positive sentiment among investors.

The stock has been highly volatile today, with an intraday volatility of 12.01%. However, it has been consistently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which is a positive sign for investors.

In the past year, Themis Medicare has shown an impressive performance with a 88.07% increase in its share price, while the Sensex has only seen a 17.76% growth. This showcases the company's strong performance and potential for growth in the pharmaceutical industry.

With its recent surge in share price and positive market sentiment, Themis Medicare is definitely a company to watch out for in the smallcap segment.